Recruiting studies: Aplastic Anemia Aa

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Revolade Tablets Specified Drug-use Survey
Phase N/A · 17 location(s) · Novartis Pharmaceuticals · NCT06287268 Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07400341 Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More
Phase 2 · 26 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06646497 Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosi
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT01624805

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.